Navamedic ASA has entered into a Share Purchase Agreement to acquire 100% of the shares in Novicus Pharma AS. The acquisition will strengthen Navamedics executive team, product pipeline and network in the pharma industry. As part of the proposed transaction, the three founders of Novicus Pharma have agreed to become key members of the Navamedic management team including Kathrine Gamborg Andreassen as CEO of Navamedic, Ole Henrik Eriksen as COO and Astrid T Bratvedt as Vice President of R&D.